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http://www.biomedcentral.com/1472-6882/13/19RESEARCH ARTICLE Open AccessEdible Bird’s nest extract as a chondro-protective
agent for human chondrocytes isolated from
osteoarthritic knee: in vitro study
Kien-Hui Chua1, Ting-Hun Lee2*, Kamini Nagandran2, Nor Hamdan Md Yahaya3, Chew-Tin Lee4,
Eddie Tan Ti Tjih5 and Ramlan Abdul Aziz2Abstract
Background: Osteoarthritis (OA) is a degenerative joint disease that results in the destruction of cartilage. Edible
Bird’s Nest (EBN) extract contains important components, which can reduce the progression of osteoarthritis and
helps in the regeneration of the cartilage. The present study aimed to investigate the effect of EBN extract on the
catabolic and anabolic activities of the human articular chondrocytes (HACs) isolated from the knee joint of patients
with OA.
Methods: A single batch of EBN extract was prepared with hot-water extraction and coded as HMG. HACs were
isolated from the knee joint cartilage removed during surgery. The optimum concentration of HMG for HAC
cultures was determined using MTT assay. The effect of HMG on the catabolic and anabolic genes’ expression in
HACs was measured by real-time PCR. The total amount of prostaglandin E2 (PGE2) production was determined by
ELISA method, and the total sulphated glycosaminoglycan (GAGs) production was quantified by
1,9-dimethylmethylene blue (DMMB) assay.
Results: MTT assay showed 0.50% - 1.00% HMG supplementation promoted HACs proliferation. HMG
supplementation was able to reduce the catabolic genes’ expression in cultured HACs such as matrix
metalloproteinases (MMP1 & MMP3), Interleukin 1, 6 and 8 (IL-1, IL-6 & IL-8), cyclooxygenase-2 (COX-2) and
inducible nitric oxide synthase (iNOS). Prostaglandin E2 (PGE2) production was significantly reduced in HAC cultures
supplemented with HMG. With regard to anabolic activity assessment, type II collagen, Aggrecan and SOX-9 gene
expression as well as sGAG production was increased in the HMG supplemented groups.
Conclusion: Edible Bird’s Nest extract coded as HMG demonstrated chondro-protection ability on human articular
chondrocytes in vitro. It reduced catabolic activities and increased cartilage extracellular matrix synthesis. It is
concluded that HMG is a potential agent in the treatment of osteoarthritis.Background
Osteoarthritis (OA) results in progressive degeneration of
the articular cartilage. OA is caused by the increase in the
production of matrix metalloproteinases (MMPs), pro-
inflammatory cytokines and catabolic mediators which
destroy the cartilage matrix [1]. Usually, there is a balance
in the anabolic and catabolic activities in the articular
chondrocytes which are involved in the remodelling of the
extracellular matrix (ECM). Disturbance in the normal* Correspondence: lee@ibd.utm.my
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reproduction in any medium, provided the orbalance triggers the pathological changes in OA and this
causes an increase in inflammatory factors and cytokine
gene expressions [2]. Pro-inflammatory cytokines such
as Interleukin-1β, 6 and 8 (IL-1β, IL-6 and IL-8) initiate
the development of OA by increasing the number of in-
flammatory cells in the synovial tissue thereby increas-
ing the amount of MMPs and inhibiting the production
of proteoglycans [3,4]. Subsequently, the release of the
catabolic mediators such as Prostaglandins E2 (PGE2),
cyclooxygenase-2 (COX-2) and inducible nitric oxide
synthase (iNOS), contribute to the catabolic conse-
quences of OA [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ganized proteoglycan and collagen network. Aggrecan
along with hyaluronic acid creates huge proteoglycan
aggregates, and forms negatively charged glycosamino-
glycan (GAG). The structure rigidity of cartilage is con-
ferred mainly by type II collagen. Type II collagen is
destroyed in cartilage injury, and it is replaced by type I
collagen which possess inferior functions [6]. The deg-
radation of both aggrecan and type II collagen contrib-
ute to the progression of OA [7,8].
One of the recent symptomatic treatments employed for
OA involves the use of non-steroidal anti-inflammatory
drugs (NSAIDs) to block cyclooxygenase (COX) [9].
NSAIDs cause an increase in damage to the cartilage. On
the other hand, usage of COX-2 specific class of NSAIDs is
known to cause cardiovascular and heart diseases [10].
Thus, there is an urgent need to identify and develop new
approaches to treat or inhibit the progression of OA.
Edible Bird’s Nest (EBN) was a significant item in the
cuisine and pharmacy of the Emperors of China during
the 16th century [11]. EBN has been known for its bene-
ficial effect in promoting health in the Chinese for thou-
sands of years [12]. In Traditional Chinese Medicine
(TCM), EBN is believed to promote the wellbeing of
multiple organs and body systems [13,14]. Previous
study showed an avian epidermal growth factor (EGF)
extracted from EBN improved the immune function and
cell proliferation [15]. Hiroki Nakagawa et al., 2007 [16]
found that EBN is rich in proteoglycans containing non-
sulfated chondroitin glycosaminoglycan (GAGs) which
shares similar properties like the matrix in the cartilage.
The proteoglycans isolated contained 83% carbohy-
drates, of which 79% were GalNAc and GlcUA (D-glu-
curonic acid) in an equimolar ratio. Recently, hot-water
extraction of EBN showed the ability to promote cornea
cells proliferation and cornea wound healing [17]. To
date, all the previous studies demonstrated the benefi-
cial effect of EBN extract prepared by water extraction.
Hence, it is hypothesized the water extraction of EBN
may prevent human articular chondrocytes (HACs) lose
its functions.
Since EBN is produced from swiftlet’s saliva, extrac-
tion method using organic solvent such as methanol,
chloroform and DMSO, which target the non-water
soluble active compound, may not be practical. The
EBN extract prepared by water extraction mainly con-
tains polysaccharide and glycoprotein, which can easily
precipitate through freezing and thawing processes.
Thus, we prepared the EBN water extract in a single
batch and stored at 4°C in order to maintain the uni-
formity and quality of the extract for the experiment.
The present study aimed to measure the effects of
EBN extract on the anabolic and catabolic activities
of HACs.Methods
Edible Bird’s nest extract
Edible Bird’s Nest (EBN) extract coded as HMG was
obtained from Chemical Engineering Pilot Plant (CEPP),
Universiti Teknologi Malaysia (UTM) using an in-house
developed method adapted from Oda et al., 1998 [18].
The EBN was collected from a bird’s house in Batu
Pahat, Johor. Briefly, EBN was grounded in a mortar and
pastel; sieved through 0.4 mm wire mesh to separate
feathers and other impurities. The grounded EBN then
underwent hot-water extraction at 80°C. The liquid was
then centrifuged to remove non-dissolved constituents.
The EBN extract was stored at 4°C until used.
Human articular chondrocytes (HACs) isolation and
culture
Prior ethical approval was obtained from the Research
and Ethical Committee of Faculty of Medicine, Universiti
Kebangsaan Malaysia (UKM project code: 06-01-06-
SF0257). Cartilage was obtained from six osteoarthritic
patients aged between 55–70 years old, who gave their
consent during total knee replacement surgery (TKR). All
patients had OA knee with lesion scored by International
Cartilage Repair Society (ICRS) of grade 4. The cartilage
was harvested from the non-weight bearing area of inter-
condylar notch distal femur. The specimen needed to have
a minimum of 300 mg remnant good cartilage, and the iso-
lated HACs expressed collagen type II mRNA with ± 20%
differences from the average. Each harvested specimen was
placed in normal saline and transported to Biotechnology
Laboratory in the Department of Physiology, Faculty of
Medicine, UKM within 24 hours. Each specimen was pro-
cessed individually to isolate the HACs. The cartilage was
separated from the bone, washed with phosphate buffered
saline (PBS; pH 7.2, Gibco, Grand Island, NY), minced into
small pieces and digested with 0.6% type II collagenase
(Worthington Biochemical Corporation, New Jersey) in
an orbital incubator at 37°C for 6–8 hours. The cell
suspension was then centrifuged at 600xg for 10 min to
pellet the HACs. The isolated HACs were then cultured in
growth medium which consisted of Ham’s F-12:Dulbecco’s
Modified Eagle’s Medium (Gibco), 10% foetal bovine serum
(FBS; Gibco), 1% of antibiotic and antimycotic (Gibco), 1%
of 50 μg/ml ascorbic acid (Sigma, St. Louis, USA) in T25
culture flasks (Nunc, Denmark). All cultures were main-
tained at 5% CO2 in a temperature of 37°C. Upon 80% con-
fluence, the HACs (Passage 0) were trypsinized using
0.125% trypsin-EDTA (Gibco) and sub-culture (passage 1)
into 6-well plates (Nunc) at the 10,000cells/cm2 seeding
density. HACs were incubated overnight in growth
medium to allow cell attachment before changed to culture
medium without FBS and ascorbic acid but supplemented
with HMG at various concentrations ranging from 0.00%
(control) to 3.00%, for seven days.
Table 1 Primers sequence of genes for quantitative PCR
Gene
Name
GenBank
Accession
Number
Primer Sequence 5′-3′ PCR product
size (bp)
GAPDH NM_002046 F: 5′-tcc ctg agc tga acg
gga ag-3′
217
R: 5′-gga gga gtg ggt
gtc gct gt-3′
COL I NM_000088 F: 5′-agg gct cca acg
aga tcg aga-3′
222
R: 5′-tac agg aag cag
aca ggg cca-3′
COL II NM_001844 F: 5′-cta tct gga cga agc
agc tgg ca-3′
209
R: 5′-atg ggt gca atg tca
atg atgg-3′
ACP NM_001135 F: 5′-gcg gag gaa gtc
ggt gaa ga-3′
183
R: 5′-ccc tct cgc ttc agg
tca gc-3′
SOX-9 NM_000346 F: 5′-cac tgt tac cgc cac
ttc cc-3′
236
R: 5′-acc agc gga agt
ccc ctt cg-3′
IL-1 NM_000576 F: 5′-gga caa gct gag
gaa gat gc-3′
120
R: 5′-tcg tta tcc cat gtg
tcg aa-3′
IL-6 NM_000600 F: 5′-tac ccc cag gag
aag att cc-3′
175
R: 5′-ttt tct gaa agt gcc
tct tt-3′
IL-8 NM_000584 F: 5′-gtg cag ttt tgc caa
gga gt-3′
196
R: 5′-ctc tgc acc cag ttt
tcc tt-3′
MMP1 NM_002421 F: 5′-agg gtt gaa aag
cat gag ca-3′
111
R: 5′-ctg gtt gaa aag cat
gag ca-3′
MMP3 NM_002422 F: 5′-tgc ttt gtc ctt tga
tgc tg-3′
135
R: 5′-gga aga gat ggc
caa aat ga-3′
MMP13 NM_002427 F: 5′-ggt ctt gac cac tcc
aag gac-3′
221
R: 5′-ctc ctc gga gac
tgg taa tgg-3′
iNOS NM_000625 F: 5′-aca agc cta ccc ctc
cag at-3′
158
R: 5′-tcc cgt cag ttg gta
ggt tc-3′
COX-2 NM_000963 F: 5′-tga gca tct acg gtt
tgc tg-3′
158
R: 5′-tgc ttg tct gga aca
act gc-3′
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The proliferation rate of each cultured HACs in different
concentration of HMG was determined by MTT Assay
using commercial kit (Sigma, USA) following seven days
of culture. The assay was started by adding 2 ml of
medium containing 0.5 mg/ml MTT into each culture
wells and incubated for 4 hours in 5% CO2 incubator at
37°C. Consequently, the formed formazan crystal was
dissolved by adding 2 ml of MTT Solubilization Solu-
tion. The solution was then transferred into 1.5 ml cu-
vette and the absorbance at 570 nm was taken three
times. Two HMG concentrations that gave the highest
cell proliferation were then used for the subsequent
experiments.
Total RNA extraction
Total RNA from cultured HACs either in HMG sup-
plemented or control group was extracted using TRI
REAGENT (Molecular Research Center, Cincinnati,
USA) according to the manufacturer’s protocol. Briefly,
chloroform was added into the TRI REAGENT hom-
ogenate to separate the colourless aqueous contained
total RNA. Next, the total RNA was precipitated from
the aqueous by mixing with isopropanol and 10 μl of
Polyacryl carrier (Molecular Research Center). The
precipitated RNA was washed with 75% ethanol and
air-dried before being dissolved in water. The yield and
the purity of the total RNA was determined by spec-
trophotometer (Bio-Rad, Hercules, USA).
CDNA synthesis
SuperScript™ III First-Strand Synthesis SuperMix
(Invitrogen, Carlsbad, USA) was used to synthesis
cDNA from extracted total RNA according to the
manufacturer’s protocol. The reverse transcription
was carried out at 50.0°C for 30 minutes and the
cDNA was stored at −20°C until use.
Quantitative polymerase chain reaction (Q PCR)
Primers used for quantitative PCR were designed based
on the sequences published in GenBank using Primer-3
software. The primers sequenced were listed (Table 1).
Quantitative PCR was performed at 94°C (pre-denaturation
step), 2 min; 40 cycles of denaturation at 94°C, 10 sec;
amplification at 61°C, 30 sec and followed by melting curve
analysis to verify the specificity of the PCR products.
The specificity of PCR product was also examined by aga-
rose gel electrophoresis. Glycerylaldehyde-3-phosphate de-
hydrogenase (GAPDH) was used as the reference gene for
the data normalization.
Prostaglandin E2 (PGE2) quantification
The culture medium from the cultured HACs at day seven
was collected and kept frozen until the concentration of
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PGE2 Immunoassay Kit (R&D Systems Inc, USA). The
sample preparation and reaction protocol was following
the manufacturer’s instruction. The absorbance at 450 nm
was acquired three times. A standard curve was plotted,
and the amount of PGE2 released in each sample was
determined from the standard curve.
Sulphated glycosaminoglycan (sGAG) quantification
The amount of sGAG in each group was measured by
1,9-dimethylmethylene blue (DMMB) assay. Chondroitin
Sulfate S (Sigma) was used as the control to plot the
standard curve. The sGAG concentration in the sample
was normalised against the DNA content in the respect-
ive specimens.
Results
HACs proliferation with HMG supplementation
The results showed HMG supplementation at low con-
centration (0.05% - 1.00%) promoted the proliferation
of HACs (Figure 1). However, HACs proliferation was
slower than the control group when HMG concentration
was higher than 1.00%. HACs recorded significant lower
proliferation in cultures supplemented with HMG at
1.80% and 3.00% concentration. Subsequently, HMG at
concentration of 0.50% and 1.00% were chosen for the
following tests.
Morphological features of HACs in the culture
The morphological feature of HACs cultured in various
HMG concentrations was captured under an inverted
microscope (Figure 2). HACs cultured at P0 in the
medium supplemented with 10% FBS appeared in polyg-
onal shape (Figure 2A). When HACs were cultured in
the medium without FBS, it lost its polygonal shape and
changed to dendrite-like features (Figure 2B). HACs cul-
tured in medium supplemented with HMG recoveredFigure 1 Human articular chondrocytes cultured in various concentra
mean ± SEM, n=6. *Significant lower proliferation compared to the controlpartially of the polygonal feature with some cells appear-
ing as fibroblastic (Figure 2C).HMG effects on the mRNA expression of HACs
HMG supplementation was able to reduce HACs expres-
sion on MMP1 and MMP3 mRNA in a dose-dependent
manner (Figure 3a and 3b). HMG concentration at 1.00%
significantly reduced the MMP1 expression by −13.27fold
compared to the control group (P=0.010) and −5.67fold
compared to the 0.5% HMG group (P=0.016). HMG con-
centration at 1.00% significantly decreased MMP3 expres-
sion by −1.56fold (P=0.047) compared to the control
group. However, HMG caused no significant increment in
the MMP13 expression in HACs compared to the control
group (Figure 3c).
HMG also caused down-regulation of IL-1, IL-6 and
IL-8 mRNA expression in HACs (Figure 4). However,
only the pro-inflammatory marker, IL-1 expression was
significantly decreased by 1.00% HMG supplementation
(−2.38fold, P=0.025; Figure 4a). Both the catabolic med-
iators; COX-2 and iNOS mRNA expression in HACs
reduced with the HMG supplementation (Figure 5).
HMG at 1.00% concentration reduced the COX-2 ex-
pression by −2.64fold and iNOS expression by −1.4fold
in cultured HACs. However, the reduction was not sig-
nificant compared to the control group.
HMG supplementation increased the anabolic gene ex-
pression of cultured HACs. The expression of COL I,
COL II, ACP and SOX-9 mRNA was increased in a dose-
dependent manner of HMG supplementation (Figure 6).
COL I expression was increased 1.15fold; COL II at
+1.28fold; ACP at +1.49fold and SOX-9 at +2.13fold with
1.00% HMG supplementation. The chondrocytes pheno-
type index (ratio of COL II/COL I) also increased in a
dose-dependent manner with HMG supplementation.
The ratio of COL II/ COL I gradually increased fromtion of HMG in the culture medium. The values were expressed as
group (P<0.05%).
Figure 2 Morphological features of cultured human articular chondrocytes (HACs). A) Freshly isolated HACs cultured in medium nourished
with 10% FBS, B) HACs cultured in medium without FBS (control), C) HACs cultured in medium supplemented with 1.00% HMG. Magnification
100×.
Figure 3 Relative gene expression level of matrix metalloproteinase in HACs cultured in medium supplemented with HMG. 3a) MMP1,
3b) MMP3 and 3c) MMP13. The values were expressed as mean ± SEM, n=6. *Significant different compared to the control group (P<0.05%).
0Significant different between HMG concentration (P < 0.05%).
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Figure 4 Relative gene expression level of pro-inflammatory markers in HACs cultured in medium supplemented with HMG. 4a) IL-1,
4b) IL-6 and 4c) IL-8. The values were expressed as mean ± SEM, n=6. *Significant different compare to the control group (P < 0.05%).
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mentation (Table 2).
Prostaglandin E2 production in HACs
The amount of PGE2 produced in HACs was decreased
by −1.12fold in 0.50% HMG supplementation. The
higher concentration of HMG at 1.00% caused a signifi-
cant decrease in PGE2 production by −1.92fold com-
pared to the control group (P=0.025; Figure 7).
Sulphated glycosaminoglycan (sGAG) production in HACs
The amount of sGAG produced by the HACs in the
control group was 2539.83±705.67 sGAG/DNA. Supple-Figure 5 Relative gene expression level of 5a) COX-2 and 5b) iNOS in
were expressed as mean ± SEM, n=6.mentation of HMG into the culture medium caused an
increase in the production of sGAG to 4718.46±1421.08
sGAG/DNA (0.50% HMG) and 3572.58±1357.89 sGAG/
DNA in 1.00% HMG (Figure 8).
Discussion
The results of the present study showed EBN extract coded
HMG worked effectively in low concentration on the HAC
cultures. HMG was able to reduce the dendritic changes
on HACs due to culture in serum-free medium. A previous
study showed cultured chondrocytes changes its morph-
ology when dedifferentiated in monolayer culture [19].
Only cultures with round-polygonal chondrocytes couldHACs cultured in medium supplemented with HMG. The values
Figure 6 Relative gene expression level of anabolic mediator in HACs cultured in medium supplemented with HMG. 6a) Type I collagen
(COL 1), 6b) Type II collagen (COL II), 6c) ACP and 6d) SOX-9. The values were expressed as mean ± SEM, n=6.
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phenotype [20]. Thus, HMG was able to reduce the den-
dritic changes and dedifferentiation on cultured HACs
compared to the control group.
Matrix metalloproteinases (MMPs) are zinc-endopepti-
dases involved in numerous physiological and pathological
events involving cartilage including degradation of both
the endogenous and newly synthesized extracellular matrix
proteins [21,22]. HMG supplementation may significantly
decrease the expression of MMP1 and MMP3 in HACs
compared to the control group. This helps in reducing the
continuous destruction of cartilage and the degenerative
progression of osteoarthritic cartilage [18,23]. The expres-
sion of pro-inflammatory cytokines (IL-1, IL-6 and IL-8) in
cultured HACs supplemented with HMG was lower com-
pared to the control group. A significant decrease in IL-1
was observed in the HMG supplemented group. IL-1 inter-
acts with various cytokines including IL-6 and IL-8 [24] to
induce the secretion of MMPs and reactive oxygen species
that destroy the cartilage matrix [25]. The capability ofTable 2 Ratio of COL II/COL I in HACs cultured in medium
supplemented with HMG
HMG Concentration COL II/COL I Index Relative to Control
Control 1
0.5% HMG 1.195
1.0% HMG 1.33HMG to suppress these cytokine’s expression may further
decrease the MMPs activity and help in the reduction of
the cartilage destruction [22].
In response to IL-1, chondrocytes increase the synthe-
sis of nitric oxide (NO) and prostaglandin E2 (PGE2)
through the activation of iNOS and cyclooxygenase-2
(COX-2) [26-28]. In this study, COX-2 and iNOS ex-
pression was reduced in HACs supplemented with
HMG. Furthermore, PGE2 production was significantly
decreased in HMG supplemented HAC cultures com-
pared to the control group. The similar results were
demonstrated in a previous study which used avocadoFigure 7 Amount of PGE2 produce in HACs cultured in medium
supplemented with HMG. The values were expressed as mean ±
SEM, n=6. *Significant lower PGE2 compared to the control group
(P<0.05).
Figure 8 Amount of GAGs production in HACs cultured in
medium supplemented with HMG. The values were expressed as
mean ± SEM, n=6.
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crease PGE2 production and down-regulate iNOS and
COX-2 expression indicated its potential use in slowing
down the cartilage destruction in OA.
In chondrocyte monolayer culture, dedifferentiation
started when type II collagen expression reduced together
with an increase of type I collagen (COL I) expression
[30]. In this study, the expression of COL I and COL II
mRNA did not state significant differences between the
HMG supplemented groups compared to the control
group. However, the ratio of COL II/COL I was increased
with the supplementation of HMG. The increase of COL
II/COL I ratio is necessary to reduce the chondrocytes’
dedifferentiation and improve the chondrocytes’ pheno-
type [31]. Besides, HMG supplementation also caused a
gradual increase in SOX-9 and aggrecan core protein
(ACP) expression in cultured HACs compared to the con-
trol group. SOX-9 is a transcription factor in chondrogen-
esis, and its expression is essential for the anabolic activity
of the chondrocyte as well as the differentiation of stem
cells [32]. While ACP is a major component of the cartil-
age matrix which helps the cartilage in sustaining continu-
ous mechanical loads [33]. In the present study, both the
ACP mRNA expression and sulphated glycosaminoglycans
(GAGs) production were increased by HMG supplementa-
tion although no significant difference was recorded. Over-
all, HMG supplementation may need a longer duration
of action before it can cause a significant increase in the
anabolic activity of the cultured HACs.
Conclusion
The catabolic activity of cultured chondrocyte was sig-
nificantly reduced with the HMG supplementation. The
ability of HMG to down-regulate MMPs, cytokines and
other catabolic mediator expression suggest that HMG
may be a potential anti-inflammatory/anti-degenerativeagent in treating osteoarthritis. HMG also causes an
increase in the chondrocytes’ anabolic activity, although
longer duration may be needed to demonstrate the
significant changes. Thus, it is concluded that HMG is a
potential chondro-protective agent.
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